Recently we reported that the AIM2 inflammasome pathway was activated in exacerbated COPD-derived PBMCs and was responsible for IL-1α and TGF-β release in a caspase-1- and caspase-4-dependent manner (Colarusso et al., 2019). Here, CASP4 is linked to chronic obstructive pulmonary disease.